• Menu
  • Skip to right header navigation
  • Skip to main content

Before Header

Link Medical Research

CRO – Contract Research Organization

  • Home
  • Solutions
    • Early Development
    • Clinical Development
    • Post-Marketing
    • LINK Advantage
    • Market Access & RWE
    • Medical Device
    • Medical Experts
    • Medical Writing
    • Pharmacovigilance
    • Clinical Operations
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Marketing Compliance
    • Biometrics
    • Other Services
  • Therapeutic areas
  • About Us
    • Our Management
    • How We Work
    • Case Studies
    • Our Memberships
  • News & Events
    • News
    • Events
    • Publications
    • Videos
  • Contact
  • Careers
    • Our Careers
    • Jobs
    • Testimonials
  • Search
  • Home
  • Solutions
    • Early Development
    • Clinical Development
    • Post-Marketing
    • LINK Advantage
    • Market Access & RWE
    • Medical Device
    • Medical Experts
    • Medical Writing
    • Pharmacovigilance
    • Clinical Operations
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Marketing Compliance
    • Biometrics
    • Other Services
  • Therapeutic areas
  • About Us
    • Our Management
    • How We Work
    • Case Studies
    • Our Memberships
  • News & Events
    • News
    • Events
    • Publications
    • Videos
  • Contact
  • Careers
    • Our Careers
    • Jobs
    • Testimonials
  • Search

Top Content

Home / Question to the Expert ft. Gunnar Danielsson and Maria Kastenfalk

Top Content 2

Question to the Expert ft. Gunnar Danielsson and Maria Kastenfalk

We’ve created a series of short under 2 minutes videos where we asked Gunnar Danielsson, former GCP inspector and Senior Regulatory Advisor at LINK Medical a couple of questions. Click on the video below to watch the YouTube playlist with the following questions. Watch on YouTube to see the full series.

1. What is the focus on an inspection?
2. What is Risk-Based Quality Management?
3. When does data become non-credible?
4. What’s important for a company when they are about to choose a CRO?
5. How early in the process should they involve a CRO?
6. Is it more cost-effective to choose a smaller CRO?
7. Do you have any tips for MedTech & Biotech companies when searching for a CRO?

After the summer we will have a live Q/A session with Gunnar.
Submit your question and join the mailing list for the invite.

Previous Post: « LINK Medical and Insife partnership combines full CRO services with powerful safety and pharmacovigilance tools
Next Post: Group Manager Regulatory CRO – Contract Research Organization»

Site Footer

Don't miss out on the latest updates

Be the first to hear our breaking news at LINK Medical

  • Home
  • Solutions
  • Therapeutic areas
  • About Us
  • News & Events
  • Contact
  • Careers
  • Search

© 2022 Link Medical Research
Privacy Policy